Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...

With political action underway through an executive order from President Donald Trump and pharmaceutical industry shifts emerging, the question remains whether these changes will lead to sustained ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.